These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
314 related items for PubMed ID: 11948400
1. Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells. Satoh T, Toyoda M, Hoshino H, Monden T, Yamada M, Shimizu H, Miyamoto K, Mori M. Oncogene; 2002 Mar 28; 21(14):2171-80. PubMed ID: 11948400 [Abstract] [Full Text] [Related]
2. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells. Bruemmer D, Yin F, Liu J, Berger JP, Sakai T, Blaschke F, Fleck E, Van Herle AJ, Forman BM, Law RE. Circ Res; 2003 Aug 22; 93(4):e38-47. PubMed ID: 12881480 [Abstract] [Full Text] [Related]
3. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells. Motomura W, Okumura T, Takahashi N, Obara T, Kohgo Y. Cancer Res; 2000 Oct 01; 60(19):5558-64. PubMed ID: 11034103 [Abstract] [Full Text] [Related]
4. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells. Yoshida K, Tanabe K, Fujii D, Oue N, Yasui W, Toge T. Anticancer Res; 2003 Oct 01; 23(1A):267-73. PubMed ID: 12680223 [Abstract] [Full Text] [Related]
6. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation. Burris TP, Pelton PD, Zhou L, Osborne MC, Cryan E, Demarest KT. Mol Endocrinol; 1999 Mar 01; 13(3):410-7. PubMed ID: 10076998 [Abstract] [Full Text] [Related]
8. Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB. Ruan H, Pownall HJ, Lodish HF. J Biol Chem; 2003 Jul 25; 278(30):28181-92. PubMed ID: 12732648 [Abstract] [Full Text] [Related]
9. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism]. Zhang M, Zou P, Bai M, Tao XN, Jin Y, Guo R. Zhonghua Yi Xue Za Zhi; 2003 Jul 10; 83(13):1169-72. PubMed ID: 12921638 [Abstract] [Full Text] [Related]
10. Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma. Takata Y, Kitami Y, Yang ZH, Nakamura M, Okura T, Hiwada K. Circ Res; 2002 Sep 06; 91(5):427-33. PubMed ID: 12215492 [Abstract] [Full Text] [Related]
11. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. Tsubouchi Y, Sano H, Kawahito Y, Mukai S, Yamada R, Kohno M, Inoue K, Hla T, Kondo M. Biochem Biophys Res Commun; 2000 Apr 13; 270(2):400-5. PubMed ID: 10753637 [Abstract] [Full Text] [Related]
12. Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists. Inoue K, Kawahito Y, Tsubouchi Y, Kohno M, Yoshimura R, Yoshikawa T, Sano H. Biochem Biophys Res Commun; 2001 Sep 28; 287(3):727-32. PubMed ID: 11563856 [Abstract] [Full Text] [Related]
13. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma. Mössner R, Schulz U, Krüger U, Middel P, Schinner S, Füzesi L, Neumann C, Reich K. J Invest Dermatol; 2002 Sep 28; 119(3):576-82. PubMed ID: 12230498 [Abstract] [Full Text] [Related]
14. Growth inhibition of esophageal squamous carcinoma cells by peroxisome proliferator-activated receptor-gamma ligands. Rumi MA, Sato H, Ishihara S, Ortega C, Kadowaki Y, Kinoshita Y. J Lab Clin Med; 2002 Jul 28; 140(1):17-26. PubMed ID: 12080324 [Abstract] [Full Text] [Related]
15. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells. Motomura W, Takahashi N, Nagamine M, Sawamukai M, Tanno S, Kohgo Y, Okumura T. Int J Cancer; 2004 Jan 01; 108(1):41-6. PubMed ID: 14618613 [Abstract] [Full Text] [Related]
16. Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung. Chang TH, Szabo E. Clin Cancer Res; 2002 Apr 01; 8(4):1206-12. PubMed ID: 11948134 [Abstract] [Full Text] [Related]
17. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway. Tsujie M, Nakamori S, Okami J, Hayashi N, Hiraoka N, Nagano H, Dono K, Umeshita K, Sakon M, Monden M. Exp Cell Res; 2003 Sep 10; 289(1):143-51. PubMed ID: 12941612 [Abstract] [Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature. Guan Y, Zhang Y, Schneider A, Davis L, Breyer RM, Breyer MD. Am J Physiol Renal Physiol; 2001 Dec 10; 281(6):F1036-46. PubMed ID: 11704554 [Abstract] [Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells. Kitamura S, Miyazaki Y, Shinomura Y, Kondo S, Kanayama S, Matsuzawa Y. Jpn J Cancer Res; 1999 Jan 10; 90(1):75-80. PubMed ID: 10076568 [Abstract] [Full Text] [Related]
20. Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells. James SY, Lin F, Kolluri SK, Dawson MI, Zhang XK. Cancer Res; 2003 Jul 01; 63(13):3531-8. PubMed ID: 12839938 [Abstract] [Full Text] [Related] Page: [Next] [New Search]